In particular, methotrexate is associated with an increased risk of NMSC in patients with a history of NMSC. Patients with rheumatoid arthritis (RA) and NMSC also have an increased risk for NMSC recurrence when treated with anti-tumor necrosis factor (anti-TNF) and methotrexate. Side effects of plaquenil mayo clinic Plaquenil lower plateltls Ok to stop taking hydroxychloroquine Chloroquine cataract Apr 10, 2019 Plaquenil is also an antirheumatic medicine and is used to treat symptoms of rheumatoid arthritis and discoid or systemic lupus erythematosus. Important information. Taking Plaquenil long-term or at high doses may cause irreversible damage to the retina of your eye. Plaquenil is an immunomodulatory drug DMARD that works by suppressing the immune system to prevent it from damaging tissues and joints. The immune system helps protect the body from harmful substances such as infectious agents and bacteria. Plaquenil has beneficial effects on 3 major aspects of lupus; skin rashes, aches & pains and fatigue. It has also been found to help in a number of other features of the disease, though less predictably. It's used to treat and prevent malaria infection, and to reduce symptoms and progression of autoimmune diseases such as lupus, rheumatoid arthritis, and others. Plaquenil is the brand name for the prescription drug hydroxychloroquine. Does plaquenil cause skin cancer Plaquenil and stomach issues." Lupus Community - Support., Plaquenil Can plaquenil cause skin cancerBest pricing hydroxychloroquine online prescriptionDiagnosis code for plaquenil screening Plaquenil and Skin cancer - from FDA reports Summary Skin cancer is found among people who take Plaquenil, especially for people who are female, 60+ old, have been taking the drug for 5 - 10 years, also take medication Enbrel, and have Multiple myeloma. Will you have Skin cancer with Plaquenil - eHealthMe. Plaqunil rash -. Did You Know This About Arthritis and Cancer Risk?. Researches Say Hydroxychloroquine Can Help Treat Cancer March 14, 2012 By Leave a Comment Researchers say a drug commonly used to treat malaria and rheumatoid arthritis has also proved effective in treating some aggressive cancers. Results from a new study reinforce a longstanding concern that the immunosuppressant and biologic agents commonly used to treat patients with autoimmune disease may increase the risk of nonmelanoma skin cancer NMSC. Summary. Hydroxychloroquine Plaquenil is a drug that is classified as an anti-malarial drug. Plaquenil is prescribed for the treatment or prevention of malaria. It is also prescribed for the treatment of rheumatoid arthritis, lupus, and the side effects of lupus such as hair loss, joint pain, and more.